RNA interference-directed caveolin-1 knockdown sensitizes SN12CPM6 cells to doxorubicin-induced apoptosis and reduces lung metastasis
- 4 September 2010
- journal article
- Published by Springer Nature in Tumor Biology
- Vol. 31 (6) , 643-650
Abstract
Human renal cell carcinoma (HRCC) is characterized by a high level of resistance to all treatment modalities. Therefore, the investigation of global gene expression in HRCC might help understand its biologic behavior and develop treatment strategies. Using cDNA microarray analysis, we initially compared gene expression profiles between HRCCs and adjacent normal tissues, and found that 87 were up-regulated and 127 genes were down-regulated. Next, a subset of genes, twofold differentially expressed, were validated by Northern blotting. Unexpectedly, caveolin-1, a gene reported to be a tumor suppressor gene, was found to be up-regulated in HRCC tissues. Expression level of caveolin-1 in SN12CPM6 (high metastatic clone) was higher than in SN12C (low metastatic clone), and SN12CPM6 was more resistant to doxorubicin (DXR) than SN12C. Caveolin-1 gene was slightly induced in surviving SN12C cells after DXR treatment. Furthermore, SN12CPM6-siCav1 cells, which were transfected with siRNA of cavelon-1 gene, were more sensitive to DXR, compared to SN12CPM6, but reduction of caveolin-1 gene expression did not affect tumor formation in subcapsule of kidney and lung metastasis. On the other hand, induction of caveolin-1 gene affected the production of lung metastasis under anti-cancer drug treatment: the incidence of pulmonary metastasis was significantly lower in SCID mice injected with SN12CPM6-siCav1 cells, and the number of pulmonary nodules decreased significantly (p = 0.0004). The above results together suggest that caveolin-1 may confer a growth advantage to cancer cells during DXR chemotherapy and surviving HRCC cells eventually might develop lung metastasis.Keywords
This publication has 28 references indexed in Scilit:
- A novel CXCL8 protein-based antagonist in acute experimental renal allograft damageMolecular Immunology, 2010
- Transforming growth factor-β as a treatment target in renal diseasesJournal Of Nephrology, 2009
- CXC and CC chemokines induced in human renal epithelial cells by inflammatory cytokinesAPMIS, 2009
- Morphological Adjustment of Senescent Cells by Modulating Caveolin-1 StatusJournal of Biological Chemistry, 2004
- Up-regulation of caveolin expression by cytotoxic agents in drug-sensitive cancer cellsAnti-Cancer Drugs, 2003
- Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells.2001
- Up-regulation of Caveolin Attenuates Epidermal Growth Factor Signaling in Senescent CellsJournal of Biological Chemistry, 2000
- Tumor cell growth inhibition by caveolin re-expression in human breast cancer cellsOncogene, 1998
- Caveolae and caveolinsCurrent Opinion in Cell Biology, 1996
- Mechanisms and Modulation of Multidrug Resistance in Primary Human Renal Cell CarcinomaJournal of Urology, 1990